FAM25A inhibitors represent a distinct class of chemical compounds designed to selectively impede the biochemical functions of the FAM25A protein. FAM25A, a protein encoded by the FAM25A gene, potentially plays a role in certain cellular processes, although its specific biological functions are not thoroughly characterized within scientific literature. Inhibitors targeting this protein would, by design, interact with the active sites or allosteric sites of FAM25A, obstructing its interaction with other molecular partners or its involvement in signaling cascades. The inhibitors are crafted to ensure high specificity to avoid off-target effects that might disrupt related proteins with similar structural motifs or domains. The chemical composition of these inhibitors is such that they bind with high affinity, diminishing the functional activity of FAM25A by stabilizing it in an inactive conformation or by preventing post-translational modifications essential for its activity.
The design of FAM25A inhibitors is a sophisticated process that takes into account the three-dimensional structure of the protein, aiming to exploit unique conformational features that are critical for its function. These inhibitors might function by mimicking the substrate or product states of FAM25A-mediated reactions, thereby acting as competitive inhibitors, or they might integrate into the regulatory regions of the protein to cause non-competitive inhibition. The action of these inhibitors is expected to result in a decrease in the normal activity of the FAM25A protein within the cell, which may influence the cellular pathways or biological processes where FAM25A is a key contributor. By reducing the functional activity of FAM25A, these inhibitors would logically alter the downstream effects mediated by the protein. The overall goal in the development of FAM25A inhibitors is to achieve precise modulation of the protein's activity without inducing toxicity or unwanted effects on other proteins or cellular functions.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $98.00 $255.00 $765.00 $1457.00 | 280 | |
Bafilomycin A1 is a potent inhibitor of vacuolar-type H+-ATPase (V-ATPase). By inhibiting V-ATPase, it disrupts lysosomal acidification and autophagy. If the activity of FAM25A is related to lysosomal function or autophagy, Bafilomycin A1 would indirectly inhibit its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of MEK, which blocks the activation of ERK. It is used to inhibit the MAPK pathway. If FAM25A is a downstream effector of this pathway, PD98059 would result in decreased FAM25A activity. | ||||||